Potential utility of sodium selenate as an adjunct to metformin in treating type ii diabetes mellitus in rats: A perspective on protein tyrosine phosphatase

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Salama, Rania M ^a   Schaalan, Mona F ^a   Elkoussi, Alaaeldin A ^b   Khalifa, Amani E ^c  

^a Egypt   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

^c African Union Organization St Abbassia   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FRUCTOSE; GLUCOSE; GLUTATHIONE; INSULIN; METFORMIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; SELENATE; STREPTOZOCIN; TRIACYLGLYCEROL; SELENIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; THERAPY EFFECT; ANIMAL; BLOOD; DRUG POTENTIATION; EXPERIMENTAL DIABETES MELLITUS; HUMAN; PATHOLOGY;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG SYNERGISM; HUMANS; HYPERGLYCEMIA; INSULIN; METFORMIN; RATS; SELENIC ACID;

EID: 84884830410     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/231378     Document Type: Article

References (52)

1. Roglic G., Unwin N., Mortality attributable to diabetes: estimates for the year 2010. Diabetes Research and Clinical Practice 2010 87 1 15 19 2-s2.0-73749086904 10.1016/j.diabres.2009.10.006
2. International Diabetes Federation (IDF, 2009): Diabetes Atlas fourth edition
3. Schinner S., Scherbaum W. A., Bornstein S. R., Barthel A., Molecular mechanisms of insulin resistance. Diabetic Medicine 2005 22 6 674 682 2-s2.0-20444399558 10.1111/j.1464-5491.2005.01566.x (Pubitemid 40805885)
4. Basciano H., Federico L., Adeli K., Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition and Metabolism 2005 2 1, article 5 2-s2.0-15744394674 10.1186/1743-7075-2-5 (Pubitemid 40412656)
5. Kim Y. D., Park K.-G., Lee Y.-S., Park Y.-Y., Kim D.-K., Nedumaran B., Jang W. G., Cho W.-J., Ha J., Lee I.-K., Lee C.-H., Choi H.-S., Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008 57 2 306 314 2-s2.0-40749116561 10.2337/db07-0381
6. Wiernsperger N. F., Bailey C. J., The antihyperglycaemic effect of metf ormin therapeutic and cellular mechanisms. Drugs 1999 58 supplement 1 31 39 2-s2.0-0032697674 (Pubitemid 129758579)
7. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 2001 108 8 1167 1174 2-s2.0-0034773404 10.1172/JCI200113505 (Pubitemid 32995375)
8. McNeill J. H., Delgatty H. L. M., Battell M. L., Insulinlike effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 1991 40 12 1675 1678 2-s2.0-0026352528
9. Becker D. J., Reul B., Ozcelikay A. T., Buchet J. P., Henquin J.-C., Brichard S. M., Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 1996 39 1 3 11 2-s2.0-0030050853 10.1007/BF00400407 (Pubitemid 26029727)
10. Kenner K. A., Anyanwu E., Olefsky J. M., Kusari J., Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. Journal of Biological Chemistry 1996 271 33 19810 19816 2-s2.0-0029810614 10.1074/jbc.271.33.19810 (Pubitemid 26281720)
11. Mueller A. S., Pallauf J., Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. Journal of Nutritional Biochemistry 2006 17 8 548 560 2-s2.0-33745971723 10.1016/j.jnutbio.2005.10.006 (Pubitemid 44066767)
12. Srinivasan K., Viswanad B., Asrat L., Kaul C. L., Ramarao P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 2005 52 4 313 320 2-s2.0-23844504364 10.1016/j.phrs.2005.05.004 (Pubitemid 41175991)
13. Matthaei S., Reibold J. P., Hamann A., Benecke H., Haring H. U., Greten H., Klein H. H., In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology 1993 133 1 304 311 2-s2.0-0027303172 10.1210/en.133.1.304 (Pubitemid 23206408)
14. Berg E. A., Wu J. Y., Campbell L., Kagey M., Stapleton S. R., Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie 1995 77 12 919 924 2-s2.0-0029563153 10.1016/0300-9084(95)80002-6 (Pubitemid 26037748)
15. Nader M. M., Eissa L. A., Gamil N. M., Ammar E.-S. M., Effect of nitric oxide, vitamin E and selenium on streptozotocin induced diabetic rats. Saudi Pharmaceutical Journal 2007 15 1 23 32 2-s2.0-33947413565 (Pubitemid 46450505)
16. Psyrogiannis A., Kyriazopoulou V., Symeonidis A., Leotsinidis M., Vagenakis A. G., Relative iron, 'overload: in offspring of patients with type 2 diabetes mellitus: a new component in the conundrum of insulin resistance syndrome?'. Hormones(Athens) 2003 2 3 161 168
17. Trinder P., Determination of blood glucose using 4-amino phenazone as oxygen acceptor. Journal of Clinical Pathology 1969 22 2, article 246 2-s2.0-0014481680
18. Morgan C. R., Lazarow A., Immunoassay of insulin using a two-antibody system. Proceedings of the Society for Experimental Biology and Medicine 1962 110 29 32 2-s2.0-2542566611
19. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
20. Allain C. C., Poon L. S., Chan C. S. G., Enzymatic determination of total serum cholesterol. Clinical Chemistry 1974 20 4 470 475 2-s2.0-0016373654
21. Wahlefeld A. W., Bergmeyer H. U., Triglycerides determination after enzymatic hydrolysis. Methods of Enzymatic Analysis 1974 New York, NY, USA Academic Press 1831 1835
22. Matsubara C., Nishikawa Y., Yoshida Y., Takamura K., A spectrophotometric method for the determination of free fatty acid in serum using acyl-coenzyme A synthetase and acyl-coenzyme A oxidase. Analytical Biochemistry 1983 130 1 128 133 2-s2.0-0020640523 (Pubitemid 13090195)
23. Nakano Y., Tajima S., Yoshimi A., Akiyama H., Tsushima M., Tanioka T., Negoro T., Tomita M., Tobe T., A novel enzyme-linked immunosorbent assay specific for high-molecular- weight adiponectin. Journal of Lipid Research 2006 47 7 1572 1582 2-s2.0-33746087647 10.1194/jlr.D600010-JLR200 (Pubitemid 44079912)
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951 193 1 265 275 2-s2.0-71849104860
25. Beutler E., Duron O., Kelly B. M., Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine 1963 61 882 888 2-s2.0-73649194769
26. Lanzetta P. A., Alvarez L. J., Reinach P. S., Candia O. A., An improved assay for nanomole amounts of inorganic phosphate. Analytical Biochemistry 1979 100 1 95 97 2-s2.0-0018600707 (Pubitemid 10157636)
27. Sözmen E. Y., Sözmen B., Delen Y., Onat T., Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. Archives of Medical Research 2001 32 4 283 287 2-s2.0-0034959143 10.1016/S0188-4409(01)00285-5 (Pubitemid 32611640)
28. Erejuwa O. O., Sulaiman S. A., Wahab M. S. A., Sirajudeen K. N. S., Salleh M. S. M., Gurtu S., Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. International Journal of Biological Sciences 2011 7 2 244 252 2-s2.0-84855538327
29. Bansal P., Paul P., Mudgal J., G. Nayak P., Thomas Pannakal S., Priyadarsini K. I., Unnikrishnan M. K., Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice. Experimental and Toxicologic Pathology 2012 64 6 651 658 2-s2.0-78650647730 10.1016/j.etp.2010. 12.009
30. Matafome P., Louro T., Rodrigues L., Crisóstomo J., Nunes E., Amaral C., Monteiro P., Cipriano A., Seiça R., Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes/Metabolism Research and Reviews 2011 27 1 54 62 2-s2.0-78651103598 10.1002/dmrr.1157
31. Hu F., Li X., Zhao L., Feng S., Wang C., Antidiabetic properties of purified polysaccharide from Hedysarum polybotrys. Canadian Journal of Physiology and Pharmacology 2010 88 1 64 72 2-s2.0-76149101266 10.1139/Y09-098
32. Da Silva Xavier G., Leclerc I., Varadi A., Tsuboi T., Moule S. K., Rutter G. A., Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochemical Journal 2003 371 3 761 774 2-s2.0-0038584871 10.1042/BJ20021812 (Pubitemid 36578875)
33. Zhang S., Kim K.-H., Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic β -cell line. Journal of Endocrinology 1995 147 1 33 41 2-s2.0-0029081369
34. Haddad P. S., Benhaddou-Andaloussi A., Martineau L., Vuong T., Meddah B., Madiraju P., Settaf A., The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content. Evidence-Based Complementary and Alternative Medicine 2011 2011 2-s2.0-79959277526 10.1155/2011/538671 538671
35. Ong K. W., Hsu A., Song L., Huang D., Tan B. K. H., Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 2011 133 2 598 607 2-s2.0-78651403392 10.1016/j.jep.2010.10.046
36. Behera G. B., Kurnool A. N., Baidya M., Kumar B. S., Bilal S., Anti-hyperglyceamic, anti-hyperlipidemic and antioxidant activity of the stem of Glinus Oppositifolius (L.) AUG. DC. International Journal of Pharmacy and Pharmaceutical Sciences 2011 3 1 1080 1090
37. Zheng X.-K., Li Y.-J., Zhang L., Feng W.-S., Zhang X., Antihyperglycemic activity of Selaginella tamariscina (Beauv.) Spring. Journal of Ethnopharmacology 2011 133 2 531 537 2-s2.0-78651395097 10.1016/j.jep.2010.10. 028
38. Metais C., Forcheron F., Abdallah P., Basset A., Del Carmine P., Bricca G., Beylot M., Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin. Metabolism 2008 57 7 946 953 2-s2.0-44949112526 10.1016/j.metabol.2008.02.010 (Pubitemid 351814687)
39. Alhaider A. A., Korashy H. M., Sayed-Ahmed M. M., Mobark M., Kfoury H., Mansour M. A., Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chemico-Biological Interactions 2011 192 3 233 242 2-s2.0-79957660441 10.1016/j.cbi.2011.03.014
40. Holland W., Morrison T., Chang Y., Wiernsperger N., Stith B. J., Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase. Biochemical Pharmacology 2004 67 11 2081 2091 2-s2.0-2342654043 10.1016/j.bcp.2004.02.016 (Pubitemid 38595489)
41. Kannappan S., Anuradha C. V., Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model. Indian Journal of Medical Research 2009 129 4 401 408 2-s2.0-70149093524
42. Roy S., Dontamalla S. K., Mondru A. K., Sannigrahi S., Veerareddy P. R., Downregulation of apoptosis and modulation of TGF- β 1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment. Biological Trace Element Research 2011 139 1 55 71 2-s2.0-78651225663 10.1007/s12011-010-8635-z
43. Aydemir-Koksoy A., Bilginoglu A., Sariahmetoglu M., Schulz R., Turan B., Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. Journal of Nutritional Biochemistry 2010 21 9 827 833 2-s2.0-77955841993 10.1016/j.jnutbio.2009.06.006
44. Bloch-Damti A., Bashan N., Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxidants and Redox Signaling 2005 7 11-12 1553 1567 2-s2.0-28844461131 10.1089/ars.2005.7.1553 (Pubitemid 41767991)
45. Mueller A. S., Pallauf J., Rafael J., The chemical form of selenium affects insulinomimetic properties of the trace element: investigations in type II diabetic dbdb mice. Journal of Nutritional Biochemistry 2003 14 11 637 647 2-s2.0-0242391073 10.1016/j.jnutbio.2003.08.001 (Pubitemid 37415266)
46. Iizuka Y., Ueda Y., Yagi Y., Sakurai E., Significant improvement of insulin resistance of GK rats by treatment with sodium selenate. Biological Trace Element Research 2010 138 1-3 265 271 2-s2.0-78649320560 10.1007/s12011-010-8622-4
47. Bayraktutan U., Free radicals, diabetes and endothelial dysfunction. Diabetes, Obesity and Metabolism 2002 4 4 224 238 2-s2.0-0035991463 10.1046/j.1463-1326.2002.00184.x (Pubitemid 34814863)
48. Bakopanos E., Silva J. E., Thiazolidinediones inhibit the expression of β 3-adrenergic receptors at a transcriptional level. Diabetes 2000 49 12 2108 2115 2-s2.0-0033656675
49. Szalkowski D., White-Carrington S., Berger J., Zhang B., Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor- α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 1995 136 4 1474 1481 2-s2.0-0028916523
50. Kintscher U., Unger T., Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers. Acta Diabetologica 2005 42 1 S26 S32 2-s2.0-18744379491 10.1007/s00592-005-0178-y
51. Brigelius-Flohé R., Tissue-specific functions of individual glutathione peroxidases. Free Radical Biology and Medicine 1999 27 9-10 951 965 2-s2.0-0033230807 10.1016/S0891-5849(99)00173-2 (Pubitemid 29507469)
52. Müller A. S., Most E., Pallauf J., Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. Journal of Animal Physiology and Animal Nutrition 2005 89 3-6 94 104 2-s2.0-17144413032 10.1111/j.1439-0396.2005.00559.x (Pubitemid 40518668)